Document/ExhibitDescriptionPagesSize 1: 8-K Current Report HTML 67K
2: EX-3.1 Articles of Incorporation/Organization or Bylaws HTML 11K
7: R1 Cover Page Cover Page HTML 56K
9: XML IDEA XML File -- Filing Summary XML 12K
12: XML XBRL Instance -- k-20240426_htm XML 23K
8: EXCEL IDEA Workbook of Financial Report Info XLSX 8K
4: EX-101.DEF XBRL Definitions -- k-20240426_def XML 43K
5: EX-101.LAB XBRL Labels -- k-20240426_lab XML 85K
6: EX-101.PRE XBRL Presentations -- k-20240426_pre XML 44K
3: EX-101.SCH XBRL Schema -- k-20240426 XSD 13K
10: JSON XBRL Instance as JSON Data -- MetaLinks 15± 21K
11: ZIP XBRL Zipped Folder -- 0000055067-24-000025-xbrl Zip 24K
(Address of principal executive offices, including zip code)
(i269)
i961-2000
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):
i☐
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
i☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
i☐
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
i☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities
registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
iCommon Stock, $.25 par value per share
iK
iNew
York Stock Exchange
i1.000% Senior Notes due 2024
iK 24
iNew York Stock Exchange
i1.250%
Senior Notes due 2025
iK 25
iNew York Stock Exchange
i0.500% Senior Notes due 2029
iK
29
iNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2 of this chapter).
i☐
Emerging
growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange
b) Carter Cast, Zack Gund, Don Knauss and Mike Schlotman were re-elected for a three-year term.
Eight matters were voted on at the 2024 Annual Meeting: the re-election of the four directors described
in (b) above; an advisory resolution to approve executive compensation; the ratification of PricewaterhouseCoopers LLP ("PwC") as the Company’s independent registered public accounting firm for fiscal year 2024; a management proposal to amend the Company's Restated Certificate of Incorporation to reflect recent Delaware law provisions regarding office exculpation; a shareowner proposal requesting adoption of a policy requiring the Board Chair to be an independent director; a shareowner proposal requesting racial and gender pay gap disclosures; a shareowner proposal requesting the Company report on the risks to the
Company associated with pesticide use in its supply chain; and a shareowner proposal requesting the Company reduce greenwashing risk.
The final results of voting on each of the matters submitted to a vote of Shareowners are as follows:
1. Election
of Directors
For
Against
Abstentions
Broker Non-Votes
1a. Carter Cast
278,297,435
2,363,168
544,525
28,683,388
1b. Zack
Gund
271,909,536
8,730,110
565,482
28,683,388
1c. Don Knauss
253,573,298
27,068,380
563,450
28,683,388
1d. Mike
Schlotman
278,117,054
2,530,632
557,442
28,683,388
For
Against
Abstentions
Broker Non-Votes
2. Advisory
resolution to approve executive compensation was approved
265,316,290
14,636,775
1,252,063
28,683,388
For
Against
Abstentions
3. Ratification
of PwC as the Company's independent registered public accounting firm was approved
290,319,061
18,971,112
598,343
For
Against
Abstentions
Broker Non-Votes
4. Management
proposal to amend the Company’s Restated Certificate of Incorporation to reflect recent Delaware law provisions regarding officer exculpation was approved
252,060,906
28,055,528
1,088,694
28,683,388
For
Against
Abstentions
Broker Non-Votes
5. Shareowner
proposal requesting adoption of a policy requiring the Board Chair to be an independent director was not approved
91,052,736
189,345,917
806,475
28,683,388
For
Against
Abstentions
Broker Non-Votes
6. Shareowner
proposal requesting racial and gender pay gap disclosures was not approved
57,228,887
222,659,006
1,317,235
28,683,388
For
Against
Abstentions
Broker Non-Votes
7. Shareowner
proposal requesting the Company report on the risks to the Company associated with pesticide use in its supply chain was not approved
60,266,751
219,076,682
1,861,695
28,683,388
For
Against
Abstentions
Broker Non-Votes
8. Shareowner
proposal requesting the Company to reduce greenwashing risk was not approved
Exhibit 104 Cover Page Interactive Data File (formatted as inline XBRL)
SIGNATURES
Pursuant to the requirements of the Securities Exchange
Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.